Ameritas Investment Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,813
Closed -$546K 2967
2016
Q4
$546K Hold
6,813
0.03% 726
2016
Q3
$543K Buy
6,813
+1,193
+21% +$96.3K 0.03% 721
2016
Q2
$438K Buy
5,620
+377
+7% +$26.9K 0.03% 671
2016
Q1
$288K Hold
5,243
0.02% 819
2015
Q4
$324K Hold
5,243
0.02% 774
2015
Q3
$331K Hold
5,243
0.02% 731
2015
Q2
$383K Hold
5,243
0.03% 720
2015
Q1
$343K Hold
5,243
0.02% 777
2014
Q4
$341K Hold
5,243
0.02% 767
2014
Q3
$315K Sell
5,243
-365
-7% -$23.8K 0.02% 778
2014
Q2
$388K Hold
5,608
0.03% 720
2014
Q1
$367K Sell
5,608
-499
-8% -$32.5K 0.03% 707
2013
Q4
$378K Buy
6,107
+82
+1% +$4.75K 0.03% 707
2013
Q3
$323K Buy
+6,025
New +$310K 0.03% 707

Other funds holding STJ

Ameritas Investment Partners's STJ Position: Q1 2017 in Review

Ameritas Investment Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,813 shares — an estimated $546K sold.

Ameritas Investment Partners first reported a position in STJ in Q3 2013 and held it in 14 quarters. The position peaked at $546K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Ameritas Investment Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Ameritas Investment Partners sold 6,813 St Jude Medical shares in Q1 2017, an estimated $546K.
  • Ameritas Investment Partners first reported a position in St Jude Medical in Q3 2013 and held it in 14 quarters.
  • Ameritas Investment Partners's St Jude Medical position peaked at $546K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Ameritas Investment Partners's 13F filing for Q1 2017, filed 9 May 2017.